Assembly Biosciences Inc

ASMB:NASDAQ

Assembly Biosciences is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients.

streetwise book logo Streetwise Company Fact Sheet

2024/5/26 17:22:11

(ASMB:NASDAQ)

Streetwise Reports Articles

08/15/2022 - View Article